We will write a custom Assessment on Prescription Drug Coverage in the UK and the UAE specifically for you
301 certified writers online
It is a well-known fact that every country has its health care system and laws that people ought to follow to obtain medical help. Moreover, every state’s parliament sets the prices of the drugs that are available in its territory. Politicians also consider some financial aid services that are intended to reduce people’s medical expenses. The following paper will describe and compare the coverage of prescription drugs in the United Kingdom and the United Arab Emirates.
Every citizen of the United Kingdom is supported by the country’s government in his or her prescription drug expenses. People from England are obliged to pay approximately fourteen dollars a month for their prescription drugs (Martin, Hartman, Benson, & Catlin, 2015). This co-payment is shared by all the residents who require financial support for certain medical expenses. However, some population categories’ medical needs cannot be covered by Her Majesty’s treasury (refugees, people with different manifestations of cancer, and other individuals that require extra financial support).
Although all citizens of England, Scotland, Wales, and Northern Ireland pay for their medical insurances regularly, the financial support covers only serious or intensive medical treatments (operations, expensive procedures, and other types of medical aid provided only by the countries’ hospitals). Moreover, if a doctor prescribes some uncommon medicaments to a patient, the client can buy all the needed items without any problems as the United Kingdom government regulates its pharmaceutical market and the prices of the medicine available in the state’s territory (Martin et al., 2015).
The Commonwealth’s health care system also allows its citizens to acquire specific prescription prepayment certificates that require their holders to pay one hundred and eighty-eight dollars per year (Martin et al., 2015). In case of emergency, a holder of such a co-payment document may obtain necessary drugs and medical treatment without any additional payments (Martin et al., 2015). In conclusion, it would be proper to say that the United Kingdom is considered to be one of the most loyal and supportive countries regarding its citizens’ prescription drug coverage.
In comparison, the health care system of the United Arab Emirates requires its residents to pay for their medical insurances. Otherwise, the local citizens might be deprived of their rights to obtain medical treatment and other necessary procedures at a discount price (Hasan, Farghadani, Alhaideri, & Fathy, 2016). Although the UK’s population significantly overweighs the number of people living in the UAE, the Queen’s state managed to solve the problem of the medication costs coverage. Nevertheless, sometimes Her Majesty’s treasury does not have enough finances to provide some new medicine to all the pharmacies in its territory.
The problem discussed above might be solved by obligating the doctors who work at governmental health institutions to prescribe more common medicine to their patients. Such an approach might prevent financial problems that the National Health Service (NHS) is responsible for at the present moment (Martin et al., 2015). It would be proper to state that the coverage of prescription drugs might have unfortunate outcomes as pharmaceutical companies rely on the country’s budget.
The United Kingdom Parliament requires its citizens to provide regular co-payments for prescription drug coverage. In turn, the United Arab Emirates government obligates the country’s residents to purchase medical insurances. However, the National Health Service of the UK sometimes runs out of finances due to expensive medicaments that have to be imported from other states. In turn, various pharmaceutical companies in Great Britain might not receive the appropriate financial support. Therefore, doctors should prescribe medicines that are more available and affordable for the government.
Hasan, S., Farghadani, G., Alhaideri, S. K., & Fathy, M. A. (2016). Pharmacist opportunities to improve public self-medicating practices in the UAE. Pharmacology & Pharmacy, 07(11), 459-471. Web.
Martin, A. B., Hartman, M., Benson, J., & Catlin, A. (2015). National Health Spending In 2014: Faster growth driven by coverage expansion and prescription drug spending. Health Affairs, 35(1), 150-160. Web.